Mismatch repair protein MSH2, cytokeratin 18 and cytokeratin 20 expression: Clinicopathological correlation and prognostic value in colorectal cancer patients

Hepato-Gastroenterology

Volumn 54, Issue 80, 2007, Pages 2266-2271

  González, Juan J ^a,c   Bernardo, Carmen G ^a   Sanz, Lourdes ^a   Fresno, Manuel F ^b   Barbón, Esther ^a   Noval, Julio G ^a   Martínez, Enrique ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c NONE   (Spain)

Author keywords

Apoptosis; Colorectal carcinoma; Cytokeratin 20; M30 Cytodeath; MSH2 expression; Prognosis factors

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 18; CYTOKERATIN 20; MISMATCH REPAIR PROTEIN; PROTEIN MSH2;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; FEMALE; HUMANS; KERATIN-18; KERATIN-20; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM INVASIVENESS; NEOPLASM STAGING;

EID: 37749010122     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bullard KM, Rothenberger DA: Colon, rectum and anus. In: Brunicardi FC, et al. (Eds.). Schwartz's Principles of Surgery. 8th Edition. New York: McGraw-Hill, 2004; pp. 1055-1117.
2. Wheeler JMD, Bodmer WF, Mortensen NJ: DNA mismatch repair genes and colorectal cancer. Gut 2000; 47:148-153.
3. Thibodeau SN, French AJ, Roche PC, et al: Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996; 56:4836-4840.
4. Bedi A, Pasricha PJ, Akhtar AJ, et al: Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995; 55:1811-1816.
5. Kim YH, Lee JH, Chun H, et al: Apoptosis and its correlation with proliferative activity in rectal cancer. J Surg Oncol 2002; 79:236-242.
6. Vlems FA, Diepstra JH, Cornelissen IM, et al: Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and down regulation in tumour tissue. Mol Pathol 2002; 55:156-163.
7. Kuramoto S, Oohara T: How do colorectal cancers develop? Cancer 1995; 75:1534-1538.
8. González Hermoso F, Lledó Matoses S: Carcinoma colorrectal. Encuesta nacional de los años 1987-1992. Cir Esp 1994; 55:423-429.
9. García-Anguiano F, Marchena J, Martín JA, Gómez G, Noguis E, Hernández J: Factores predictivos de la recidiva de cáncer colorrectal. Cir Esp 2001; 70:267-273.
10. Biondo S, Martí-Ragiu J: Cáncer colorrectal ¿Qui factores pueden ser determinantes en su curación o recidiva? Cir Esp 2001; 70:265-266.
11. Pokorny RM, Hunt LE, Galandiuk S: What's new with tumor markers for colorectal cancer? Dig Surg 2000; 17:209-215.
12. Li GM: DNA mismatch repair and cancer Front Biosci 2003; 8:d997-1017.
13. Raevaara TE, Vaccaro C, Abdel-Rahman WM, et al: Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein. Gastroenterology 2003; 125:501-509.
14. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363:558-561.
15. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 1993; 260:816-819.
16. Park IJ, Kim HC, Kim JS, Yu ES, Yu CS, Kim JC: Correlation between hMLH1/ hMSH2 and p53 protein expression in sporadic colorectal cancer. Hepatogastroenterology 2005; 52:450-454.
17. Lanza G, Gafa R, Maestri I, Santini A, Matteuzzi M, Cavazzini L: Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Mod Pathol 2002; 15:741-749.
18. Kruschewski M, Noske A, Haier J, Runkel N, Anagnostopoulos Y, Buhr HJ: Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis? Clin Exp Metastasis 2002; 19:71-77.
19. Cotran RS, Kumar V, Collins T: Pathologic basis of disease. 6th Edition. United States of America: W.B. Saunders Company, 1999.
20. Leers MP, Kolgen W, Bjorklund V, et al: Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 1999; 187:567-572.
21. Backus HH, Van Groeningen CJ, Vos W, et al: Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumors, and liver metastases. J Clin Pathol 2002; 55:206-211.
22. Michael-Robinson JM, Biemer-Huttmann A, Purdie DM, et al: Tumor infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 2001; 48:360-366.
23. Kummar S, Forgarasi M, Canova A, Mota A, Ciesielski T: Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. Br J. Cancer 2002; 86:1884-1887.
24. Loy TS, Calaluce RD: Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 1994; 102:764-767.
25. Car NJ: M30 expression demonstrates apoptotic cells, correlates with in situ en-labeling, and is associated with Ki-67 expression in large intestinal neoplasm. Arch Pathol Lab Med 2000; 124:1768-1771.
26. Merrie AE, van Rij AM, Dennett ER, Phillips LV, Yun K, McCall JL: Prognostic significance of occult metastases in colon cancer. Dis Colon Rectum 2003; 46:221-231.
27. Gradilone A, Gazzaniga P, Silvestri I, et al: Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: Correlation with clinical stage of disease. Oncol Rep 2003; 10:217-222.
28. Jansson A, Arbman G, Zhang H, Sun XF: Combined deficiency of hMLH1, hMSH2, hMSH3 and hMSH6 is an independent prognostic factor in colorectal cancer. Int J Oncol 2003; 22:41-49.
29. Perrin J, Gouvernet J, Parriaux D, et al: MSH2 and MLH1 immunodetection and the prognosis of colon cancer. Int J Oncol 2001; 19:891-895.
30. Farrington SM, McKinley AJ, Carothers AD, et al: Evidence for an age-related influence of microsatellite instability on colorectal cancer survival. Int J Cancer 2002; 98:844-850.
31. Garrity MM, Burgart LJ, Mahoney MR, et al: North Central Cancer Treatment Group: Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol 2004; 22:1572-1582.
32. Horkko TT, Makinen MJ: Colorectal proliferation and apoptosis in serrated versus conventional adenoma-carcinoma pathway: growth, progression and survival. Scand J Gastroenterol 2003; 38:1241-1248.
33. Noguchi T, Kikuchi R, Ono K, Takeno S, Moriyama H, Uchida Y: Prognostic significance of p27/kipl and apoptosis in patients with colorectal carcinoma. Oncol Rep 2003; 10:827-831.
34. Bendardaf R, Ristamaki R, Kujari H, et al: Apoptotic index and bcl-2 expression as prognostic factors in colorectal carcinoma. Oncology 2003; 64:435-442.
35. Rupa JD, de Bruine AP, Gerbers AJ, et al: Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low-turnover tumors with distinct clinical outcome. Cancer 2003; 97:2404-2411.
36. Fujita S, Kudo N, Akasu T, Moriya Y: Detection of cytokeratin 19 and 20 mRNA in peripheral and mesenteric blood from colorectal cancer patients and their prognosis. Int J Colorectal Dis 2001; 16:141-146.
37. Lassmann S, Bauer M, Rosenberg R, et al: Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression. Int J Colorectal Dis 2004; 19:87-94.
38. Rosenberg R, Hoos A, Mueller J, et al: Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 2002; 20:1049-1055.
39. Laso CA, González JJ, Fresno F, Azcano E, Sanz L, Navarrete F: Prognostic value of micrometastases in esophageal and colorectal carcinoma (a clinical experience). Hepatogastroenterology 2004; 51:964-967.